Literature DB >> 7320512

A novel immunization procedure for production of anti-cholecystokinin-specific antiserum of low cross-reactivity.

K Tateishi, T Hamaoka, N Sugiura, C Yanaihara, N Yanaihara.   

Abstract

An anti-cholecystokinin octapeptide (CCK-8) antibody without cross-reactivity with pentagastrin, whose amino acid sequence is identical with the carboxy-terminal portion of CCK-8, was produced by immunization with CCK-8-keyhole limpet hemocyanin and injection of a conjugate of pentagastrin and a copolymer of D-glutamic acid and D-lysine to inhibit production of antibody cross-reacting with pentagastrin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7320512     DOI: 10.1016/0022-1759(81)90125-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Impaired pancreatic exocrine function in rats with carbon tetrachloride-induced liver cirrhosis.

Authors:  T Ogasawara; T Inagaki; T Yamada; H Ohara; T Nakazawa; M Itoh
Journal:  Int J Pancreatol       Date:  1999-10

2.  Cholecystokinin cells purified by fluorescence-activated cell sorting respond to monitor peptide with an increase in intracellular calcium.

Authors:  R A Liddle; M A Misukonis; L Pacy; A E Balber
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  Effect of oral protease inhibitor administration on gallbladder motility in patients with mild chronic pancreatitis.

Authors:  M Sugiyama; Y Atomi; N Wada; A Kuroda; T Muto
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.